US President Donald Trump is preparing to impose substantial tariffs on imported generic drugs, potentially up to 200%, following the expiration of existing tariffs on Friday. This announcement signals a renewed push for protectionist trade policies by the administration. The move could significantly increase the cost of prescription medications for American consumers, as generic drugs offer more affordable alternatives to brand-name options. Industry analysts predict potential supply chain disruptions and retaliatory measures from affected countries. While the White House has not released detailed justifications, the tariffs are reportedly aimed at incentivizing domestic pharmaceutical production. The impacted tariffs were previously set to expire, giving way to the new, potentially steeper levies. This development marks a shift in Trump’s trade strategy and could impact international trade relations.